Assembly Biosciences
ASMB
27 hedge funds and large institutions have $16.1M invested in Assembly Biosciences in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
87% more capital invested
Capital invested by funds: $8.61M → $16.1M (+$7.5M)
13% more funds holding
Funds holding: 24 → 27 (+3)
7.24% more ownership
Funds ownership: 11.81% → 19.05% (+7.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$6.67M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$248K |
| 3 |
Renaissance Technologies
New York
|
+$220K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$182K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$110K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$20.9K |
| 2 |
BlackRock
New York
|
-$10.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.08K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.1K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
ASMB Hedge Fund Activity: Q2 2024 in Review
27 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2024, worth a combined $16.1M — up 87% from $8.61M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ASMB positions and 2 closed out — a net gain of 3 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $6.67M. The largest seller was Millennium Management, cutting an estimated $20.9K.
- 27 institutional investors held Assembly Biosciences (ASMB) as of Q2 2024, up from 24 in Q1 2024.
- Funds reported $16.1M of Assembly Biosciences stock for Q2 2024, up 87% quarter-over-quarter.
- 5 funds opened new Assembly Biosciences positions in Q2 2024 and 2 closed out, a net change of +3 holders.
- The largest Assembly Biosciences buyer in Q2 2024 was Armistice Capital, an estimated $6.67M added.
- The largest Assembly Biosciences seller in Q2 2024 was Millennium Management, an estimated $20.9K sold.
Based on aggregated 13F filings for Q2 2024.